- call +1-201-465-4211
- email sales@mrinsights.biz
DPP IV inhibitors are a class of hypoglycemic agents that block the enzyme named dipeptidyl peptidase IV. Dipeptidyl peptidase IV enzyme break down the proteins that are responsible for stimulating the insulin producing cells that slows down gastric secretion. Proteins can activate the release of insulin and can control the blood sugar level if DPP IV is inhibited in our body.
Scope of the Report:
This report focuses on the DPP IV Inhibitors (DPP-4 Inhibitors) in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Geographically, North America and Europe dominates the global market for DPP IV inhibitors due to high prevalence rate and rising awareness among people about the DPP IV inhibitors. Asia-Pacific is considered as a fastest growing market due to increasing obese population.
The worldwide market for DPP IV Inhibitors (DPP-4 Inhibitors) is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
AstraZeneca
Boehringer
Eli Lilly
Merck
Mitsubishi Tanabe Pharma
Novartis
Takeda
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Sitagliptin
Vildagliptin
Saxagliptin
Linagliptin
Others
Market Segment by Applications, can be divided into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
There are 15 Chapters to deeply display the global DPP IV Inhibitors (DPP-4 Inhibitors) market.
Chapter 1, to describe DPP IV Inhibitors (DPP-4 Inhibitors) Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of DPP IV Inhibitors (DPP-4 Inhibitors), with sales, revenue, and price of DPP IV Inhibitors (DPP-4 Inhibitors), in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of DPP IV Inhibitors (DPP-4 Inhibitors), for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, DPP IV Inhibitors (DPP-4 Inhibitors) market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe DPP IV Inhibitors (DPP-4 Inhibitors) sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 DPP IV Inhibitors (DPP-4 Inhibitors) Introduction
1.2 Market Analysis by Type
1.2.1 Sitagliptin
1.2.2 Vildagliptin
1.2.3 Saxagliptin
1.2.4 Linagliptin
1.2.5 Others
1.3 Market Analysis by Applications
1.3.1 Hospital Pharmacies
1.3.2 Retail Pharmacies
1.3.3 Online Pharmacies
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 AstraZeneca
2.1.1 Business Overview
2.1.2 DPP IV Inhibitors (DPP-4 Inhibitors) Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 AstraZeneca DPP IV Inhibitors (DPP-4 Inhibitors) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Boehringer
2.2.1 Business Overview
2.2.2 DPP IV Inhibitors (DPP-4 Inhibitors) Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Boehringer DPP IV Inhibitors (DPP-4 Inhibitors) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Eli Lilly
2.3.1 Business Overview
2.3.2 DPP IV Inhibitors (DPP-4 Inhibitors) Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Eli Lilly DPP IV Inhibitors (DPP-4 Inhibitors) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Merck
2.4.1 Business Overview
2.4.2 DPP IV Inhibitors (DPP-4 Inhibitors) Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Merck DPP IV Inhibitors (DPP-4 Inhibitors) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Mitsubishi Tanabe Pharma
2.5.1 Business Overview
2.5.2 DPP IV Inhibitors (DPP-4 Inhibitors) Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Mitsubishi Tanabe Pharma DPP IV Inhibitors (DPP-4 Inhibitors) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Novartis
2.6.1 Business Overview
2.6.2 DPP IV Inhibitors (DPP-4 Inhibitors) Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Novartis DPP IV Inhibitors (DPP-4 Inhibitors) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Takeda
2.7.1 Business Overview
2.7.2 DPP IV Inhibitors (DPP-4 Inhibitors) Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Takeda DPP IV Inhibitors (DPP-4 Inhibitors) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global DPP IV Inhibitors (DPP-4 Inhibitors) Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global DPP IV Inhibitors (DPP-4 Inhibitors) Sales and Market Share by Manufacturer (2016-2017)
3.2 Global DPP IV Inhibitors (DPP-4 Inhibitors) Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 DPP IV Inhibitors (DPP-4 Inhibitors) Manufacturer Market Share in 2017
3.3.2 Top 6 DPP IV Inhibitors (DPP-4 Inhibitors) Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global DPP IV Inhibitors (DPP-4 Inhibitors) Market Analysis by Regions
4.1 Global DPP IV Inhibitors (DPP-4 Inhibitors) Sales, Revenue and Market Share by Regions
4.1.1 Global DPP IV Inhibitors (DPP-4 Inhibitors) Sales and Market Share by Regions (2013-2018)
4.1.2 Global DPP IV Inhibitors (DPP-4 Inhibitors) Revenue and Market Share by Regions (2013-2018)
4.2 North America DPP IV Inhibitors (DPP-4 Inhibitors) Sales and Growth Rate (2013-2018)
4.3 Europe DPP IV Inhibitors (DPP-4 Inhibitors) Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific DPP IV Inhibitors (DPP-4 Inhibitors) Sales and Growth Rate (2013-2018)
4.5 South America DPP IV Inhibitors (DPP-4 Inhibitors) Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa DPP IV Inhibitors (DPP-4 Inhibitors) Sales and Growth Rate (2013-2018)
5 North America DPP IV Inhibitors (DPP-4 Inhibitors) by Countries
5.1 North America DPP IV Inhibitors (DPP-4 Inhibitors) Sales, Revenue and Market Share by Countries
5.1.1 North America DPP IV Inhibitors (DPP-4 Inhibitors) Sales and Market Share by Countries (2013-2018)
5.1.2 North America DPP IV Inhibitors (DPP-4 Inhibitors) Revenue and Market Share by Countries (2013-2018)
5.2 United States DPP IV Inhibitors (DPP-4 Inhibitors) Sales and Growth Rate (2013-2018)
5.3 Canada DPP IV Inhibitors (DPP-4 Inhibitors) Sales and Growth Rate (2013-2018)
5.4 Mexico DPP IV Inhibitors (DPP-4 Inhibitors) Sales and Growth Rate (2013-2018)
6 Europe DPP IV Inhibitors (DPP-4 Inhibitors) by Countries
6.1 Europe DPP IV Inhibitors (DPP-4 Inhibitors) Sales, Revenue and Market Share by Countries
6.1.1 Europe DPP IV Inhibitors (DPP-4 Inhibitors) Sales and Market Share by Countries (2013-2018)
6.1.2 Europe DPP IV Inhibitors (DPP-4 Inhibitors) Revenue and Market Share by Countries (2013-2018)
6.2 Germany DPP IV Inhibitors (DPP-4 Inhibitors) Sales and Growth Rate (2013-2018)
6.3 UK DPP IV Inhibitors (DPP-4 Inhibitors) Sales and Growth Rate (2013-2018)
6.4 France DPP IV Inhibitors (DPP-4 Inhibitors) Sales and Growth Rate (2013-2018)
6.5 Russia DPP IV Inhibitors (DPP-4 Inhibitors) Sales and Growth Rate (2013-2018)
6.6 Italy DPP IV Inhibitors (DPP-4 Inhibitors) Sales and Growth Rate (2013-2018)
7 Asia-Pacific DPP IV Inhibitors (DPP-4 Inhibitors) by Countries
7.1 Asia-Pacific DPP IV Inhibitors (DPP-4 Inhibitors) Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific DPP IV Inhibitors (DPP-4 Inhibitors) Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific DPP IV Inhibitors (DPP-4 Inhibitors) Revenue and Market Share by Countries (2013-2018)
7.2 China DPP IV Inhibitors (DPP-4 Inhibitors) Sales and Growth Rate (2013-2018)
7.3 Japan DPP IV Inhibitors (DPP-4 Inhibitors) Sales and Growth Rate (2013-2018)
7.4 Korea DPP IV Inhibitors (DPP-4 Inhibitors) Sales and Growth Rate (2013-2018)
7.5 India DPP IV Inhibitors (DPP-4 Inhibitors) Sales and Growth Rate (2013-2018)
7.6 Southeast Asia DPP IV Inhibitors (DPP-4 Inhibitors) Sales and Growth Rate (2013-2018)
8 South America DPP IV Inhibitors (DPP-4 Inhibitors) by Countries
8.1 South America DPP IV Inhibitors (DPP-4 Inhibitors) Sales, Revenue and Market Share by Countries
8.1.1 South America DPP IV Inhibitors (DPP-4 Inhibitors) Sales and Market Share by Countries (2013-2018)
8.1.2 South America DPP IV Inhibitors (DPP-4 Inhibitors) Revenue and Market Share by Countries (2013-2018)
8.2 Brazil DPP IV Inhibitors (DPP-4 Inhibitors) Sales and Growth Rate (2013-2018)
8.3 Argentina DPP IV Inhibitors (DPP-4 Inhibitors) Sales and Growth Rate (2013-2018)
8.4 Colombia DPP IV Inhibitors (DPP-4 Inhibitors) Sales and Growth Rate (2013-2018)
9 Middle East and Africa DPP IV Inhibitors (DPP-4 Inhibitors) by Countries
9.1 Middle East and Africa DPP IV Inhibitors (DPP-4 Inhibitors) Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa DPP IV Inhibitors (DPP-4 Inhibitors) Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa DPP IV Inhibitors (DPP-4 Inhibitors) Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia DPP IV Inhibitors (DPP-4 Inhibitors) Sales and Growth Rate (2013-2018)
9.3 UAE DPP IV Inhibitors (DPP-4 Inhibitors) Sales and Growth Rate (2013-2018)
9.4 Egypt DPP IV Inhibitors (DPP-4 Inhibitors) Sales and Growth Rate (2013-2018)
9.5 Nigeria DPP IV Inhibitors (DPP-4 Inhibitors) Sales and Growth Rate (2013-2018)
9.6 South Africa DPP IV Inhibitors (DPP-4 Inhibitors) Sales and Growth Rate (2013-2018)
10 Global DPP IV Inhibitors (DPP-4 Inhibitors) Market Segment by Type
10.1 Global DPP IV Inhibitors (DPP-4 Inhibitors) Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global DPP IV Inhibitors (DPP-4 Inhibitors) Sales and Market Share by Type (2013-2018)
10.1.2 Global DPP IV Inhibitors (DPP-4 Inhibitors) Revenue and Market Share by Type (2013-2018)
10.2 Sitagliptin Sales Growth and Price
10.2.1 Global Sitagliptin Sales Growth (2013-2018)
10.2.2 Global Sitagliptin Price (2013-2018)
10.3 Vildagliptin Sales Growth and Price
10.3.1 Global Vildagliptin Sales Growth (2013-2018)
10.3.2 Global Vildagliptin Price (2013-2018)
10.4 Saxagliptin Sales Growth and Price
10.4.1 Global Saxagliptin Sales Growth (2013-2018)
10.4.2 Global Saxagliptin Price (2013-2018)
10.5 Linagliptin Sales Growth and Price
10.5.1 Global Linagliptin Sales Growth (2013-2018)
10.5.2 Global Linagliptin Price (2013-2018)
10.6 Others Sales Growth and Price
10.6.1 Global Others Sales Growth (2013-2018)
10.6.2 Global Others Price (2013-2018)
11 Global DPP IV Inhibitors (DPP-4 Inhibitors) Market Segment by Application
11.1 Global DPP IV Inhibitors (DPP-4 Inhibitors) Sales Market Share by Application (2013-2018)
11.2 Hospital Pharmacies Sales Growth (2013-2018)
11.3 Retail Pharmacies Sales Growth (2013-2018)
11.4 Online Pharmacies Sales Growth (2013-2018)
12 DPP IV Inhibitors (DPP-4 Inhibitors) Market Forecast (2018-2023)
12.1 Global DPP IV Inhibitors (DPP-4 Inhibitors) Sales, Revenue and Growth Rate (2018-2023)
12.2 DPP IV Inhibitors (DPP-4 Inhibitors) Market Forecast by Regions (2018-2023)
12.2.1 North America DPP IV Inhibitors (DPP-4 Inhibitors) Market Forecast (2018-2023)
12.2.2 Europe DPP IV Inhibitors (DPP-4 Inhibitors) Market Forecast (2018-2023)
12.2.3 Asia-Pacific DPP IV Inhibitors (DPP-4 Inhibitors) Market Forecast (2018-2023)
12.2.4 South America DPP IV Inhibitors (DPP-4 Inhibitors) Market Forecast (2018-2023)
12.2.5 Middle East and Africa DPP IV Inhibitors (DPP-4 Inhibitors) Market Forecast (2018-2023)
12.3 DPP IV Inhibitors (DPP-4 Inhibitors) Market Forecast by Type (2018-2023)
12.3.1 Global DPP IV Inhibitors (DPP-4 Inhibitors) Sales Forecast by Type (2018-2023)
12.3.2 Global DPP IV Inhibitors (DPP-4 Inhibitors) Market Share Forecast by Type (2018-2023)
12.4 DPP IV Inhibitors (DPP-4 Inhibitors) Market Forecast by Application (2018-2023)
12.4.1 Global DPP IV Inhibitors (DPP-4 Inhibitors) Sales Forecast by Application (2018-2023)
12.4.2 Global DPP IV Inhibitors (DPP-4 Inhibitors) Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure DPP IV Inhibitors (DPP-4 Inhibitors) Picture
Table Product Specifications of DPP IV Inhibitors (DPP-4 Inhibitors)
Figure Global Sales Market Share of DPP IV Inhibito
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
